11 results · 21ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

Blood Pressure Monitor (TMB-2092-G)

FDA 510(k)
FDA Class 2 ·Cardiovascular

LCP

FDA UDI
Synthes GmbH·10886982166852·LCP ONE-THIRD TUBULAR PLATE WITH COLLAR 5 HOLES...

Portex

FDA UDI
ICU MEDICAL, INC.·15019517085297·

Broach 35.5 size 1

FDA UDI
SIGNATURE ORTHOPAEDICS PTY LTD·09348215055363·

Maxima Surgical Gown

FDA 510(k)
FDA Class 2 ·General, Plastic Surgery

SUPERCHECK PLUS BLOOD GLUCOSE MONITORING SYSTEM, SUPER CHECK PLUS MULTI BLOOD GLUCOSE MONITORING SYSTEM

FDA 510(k)
FDA Class 2 ·Clinical Chemistry

SILTEX CHP LUMERA GEL, 485CC

FDA Adverse Event
Injury ·MENTOR TEXAS·Product code FTR·February 13, 2019

ACCU-CHEK ® AVIVA PLUS TEST STRIPS

FDA Adverse Event
Malfunction ·ROCHE DIAGNOSTICS·Product code LFR·November 10, 2014

INSTATRAK 3500

FDA Adverse Event
Malfunction ·GE OEC MEDICAL SYSTEMS (SLC)·Product code LLZ·August 17, 2011

IN TOUCH EU

FDA Adverse Event
Malfunction ·STRYKER MEDICAL-KALAMAZOO·Product code FNL·July 22, 2013

Boston Scientific TELIGEN, Implantable Cardiac Defibrillator models E102, E110, the following models are not available in the US: models E103, E111, F102, F103, F110, F111. Sterilized using ethylene oxide. Product Usage: This family of implantable cardioverter defibrillators (ICDs) provide a variety of therapies including: -Ventricular tachyarrhythmia therapy, which is used to treat rhythms associated with sudden cardiac death such as VT and VF; -Bradycardia pacing, including adaptive rate pacing, to detect and treat bradyarrhythmias and to provide cardiac rate support after defibrillation therapy. Boston Scientific implantable cardioverter defibrillators (ICDs) are indicated to provide ventricular antitachycardia pacing (ATP) and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias

FDA Enforcement
Class II ·Terminated·Boston Scientific CRM Corp·October 29, 2014